Programa para la adecuación del uso de paracetamol a dosis menores y más seguras: implantación y resultados

por García-Muñoz, Carmen, Rivas-Clemente, Francisco P.J., Fernandez-Esteban, Inmaculada, Calleja-Hernandez, Miguel Angel
Publicado 2019

Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication—A Systematic Review

por Pereira-Céspedes, Alfonso, Jiménez-Morales, Alberto, Palomares-Bayo, Magdalena, Martínez-Martínez, Fernando, Calleja-Hernández, Miguel Ángel
Publicado 2023

Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study

por Fernández‐López, Cristina, Calleja‐Hernández, Miguel Ángel, Balbino, Jaime Espín, Cabeza‐Barrera, José, Expósito‐Hernández, José
Publicado 2019

Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice

por Lozano-Blázquez, Ana, Calvo-Pita, Cecilia, Carbajales-Álvarez, Mónica, Suárez-Gil, Patricio, Martínez-Martínez, Fernando, Calleja-Hernández, Miguel Ángel
Publicado 2014

Trends in phase III randomized controlled clinical trials on the treatment of advanced non‐small‐cell lung cancer

por Fernández‐López, Cristina, Expósito‐Hernández, José, Arrebola‐Moreno, Juan Pedro, Calleja‐Hernández, Miguel Ángel, Expósito‐Ruíz, Manuela, Guerrero‐Tejada, Rosa, Linares, Isabel, Cabeza‐Barrera, José
Publicado 2016

Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis

por Zarzuelo Romero, María José, Pérez Ramírez, Cristina, Carrasco Campos, María Isabel, Sánchez Martín, Almudena, Calleja Hernández, Miguel Ángel, Ramírez Tortosa, María Carmen, Jiménez Morales, Alberto
Publicado 2021

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results

por Argüelles-Arias, Federico, Guerra Veloz, Maria Fernanda, Perea Amarillo, Raul, Vilches-Arenas, Angel, Castro Laria, Luisa, Maldonado Pérez, Belen, Chaaro Benallal, Dina, Benítez Roldán, Antonio, Merino, Vicente, Ramirez, Gabriel, Calleja-Hernández, Miguel Angel, Caunedo Álvarez, Angel, Romero Gómez, Manuel
Publicado 2017

Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study

por Rubio-Salvador, Ana Rosa, Escudero-Vilaplana, Vicente, Marcos Rodríguez, José Antonio, Mangues-Bafalluy, Irene, Bernardez, Beatriz, García Collado, Carlos, Collado-Borrell, Roberto, Alvarado Fernández, María Dolores, Chacón López-Muñiz, José Ignacio, Yébenes Cortés, María, Gómez Barrera, Manuel, Calleja-Hernández, Miguel Ángel
Publicado 2021